TerminatedNCT04566445
HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
PHASE2 · 255 planned enrolment
- Countries listed
- 7
- Registry update
- January 28, 2026
immortal.lifeTrial registrations containing the exact intervention label GT005.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 255 planned enrolment
PHASE1 · PHASE2 · 56 planned enrolment
PHASE2 · 98 planned enrolment